Gonadal function and immunosuppressive therapy after renal transplantation

V. Tondolo, F. Citterio, N. Panocchia, G. Nanni, E. Favi, A. Brescia, M. Castagneto

Research output: Contribution to journalArticle


End-stage renal disease is associated with disorders in hypothalamic-pituitary-gonadal function. Immunosuppressive therapies may influence the restoration of normal levels of gonadal hormones after renal transplantation. The aim of the present study was to evaluate the hormonal status of successful renal transplant recipients who were treated with different immunosuppressive agents. Testosterone, luteinizing hormone (LH), and follicle stimulating hormone (FSH) were measured in 59 male renal transplant recipients with stable graft function with serum creatinine

Original languageEnglish
Pages (from-to)1915-1917
Number of pages3
JournalTransplantation Proceedings
Issue number4
Publication statusPublished - May 2005

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Fingerprint Dive into the research topics of 'Gonadal function and immunosuppressive therapy after renal transplantation'. Together they form a unique fingerprint.

  • Cite this

    Tondolo, V., Citterio, F., Panocchia, N., Nanni, G., Favi, E., Brescia, A., & Castagneto, M. (2005). Gonadal function and immunosuppressive therapy after renal transplantation. Transplantation Proceedings, 37(4), 1915-1917. https://doi.org/10.1016/j.transproceed.2005.04.004